# Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428

**Authors:** Dengxiao Lin, Wenfeng Yu, Jia Yu, Sha Cheng, Yu Song, Xiaoqing Wan, Yingjiang Xu, Heng Luo, Baofei Sun

PMC · DOI: 10.3390/ph18060815 · Pharmaceuticals · 2025-05-29

## Full-text entities

- **Genes:** CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, PLAU (plasminogen activator, urokinase) [NCBI Gene 5328] {aka ATF, BDPLT5, QPD, UPA, URK, u-PA}
- **Diseases:** Glioblastoma (MESH:D005909)
- **Chemicals:** Huafengdan (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12196475/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12196475/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12196475/full.md

---
Source: https://tomesphere.com/paper/PMC12196475